RESEARCH-USE BIOSIMILAR ANTIBODY
Vedolizumab
Monoclonal antibody · IgG1
Vedolizumab is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
TARGETITGA4
YMonoclonal antibody
TARGETITGB7
CATALOG NUMBERSC-BS-042
MOLECULAR WEIGHTApprox. 146.868 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Vedolizumab is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
Vedolizumab is a recombinant research-use antibody directed against ITGA4 / ITGB7.